Targeted Therapy Improves Real-World Survival in Patients with Molecularly Matched Advanced Biliary Tract Cancer
Tanios Bekaii‐Saab(WinnMed), Masafumi Ikeda(National Cancer Center Hospital East), Ashley Moyer(Duke University), Oluseyi Abidoye(Mayo Clinic), Yoshiaki Nakamura(National Cancer Center Hospital East), Taro Shibuki(National Cancer Center Hospital East), Mitesh J. Borad(Jacksonville College), Yasuyuki Kawamoto(Hokkaido University Hospital), Nguyen H. Tran(The University of Sydney), Christina Wu(Mayo Clinic Hospital), Tadayoshi Hashimoto(Osaka University), Heidi Kosiorek(Mayo Clinic in Florida), Lewis R. Roberts(Mayo Clinic), Binbin Zheng-Lin(WinnMed), Hideaki Bando(Aichi Cancer Center), Shinji Itoh(Kyushu University), Cody Eslinger(WinnMed), Makoto Ueno(Kanagawa Prefectural Hospital Organization), Hani M. Babiker, Mohamad Bassam Sonbol(WinnMed), Takayuki Yoshino(University of Tsukuba), Takao Fujisawa(Osaka Prefectural Medical Center), Daniel H. Ahn(Mayo Clinic Hospital), Chigusa Morizane, Ryne C. Ramaker(Duke Medical Center), Mitsuho Imai(National Cancer Center Hospital East), Celine Hoyek(Mayo Clinic Hospital), Angelo Pirozzi(Humanitas University), Madhuri Gottam, John H. Strickler(Duke Medical Center)
Cited by 0
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k